An unexpected central hypertensive effect of the new imidazoline compound benazoline.
Bruban
V
V
Laboratoire de Neurobiologie et Pharmacologie Cardiovasculaire, Université Louis Pasteur, CNRS, Strasbourg, France.
Feldman
J
J
Dontenwill
M
M
Greney
H
H
Brasili
L
L
Giannella
M
M
Pigini
M
M
Bousquet
P
P
D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects*; D006339:Heart Rate / Q000187:drug effects; D006973:Hypertension / Q000139:chemically induced*; D007093:Imidazoles / Q000494:pharmacology*; D054755:Imidazoline Receptors; D008297:Male; D014663:Nasal Decongestants / Q000494:pharmacology; D010080:Oxazoles / Q000494:pharmacology; D011817:Rabbits; D011955:Receptors, Drug / Q000378:metabolism; D000077769:Rilmenidine; D013564:Sympathetic Nervous System / Q000187:drug effects / Q000502:physiology; D015016:Yohimbine / Q000494:pharmacology
D000959:Antihypertensive Agents; D007093:Imidazoles; D054755:Imidazoline Receptors; D014663:Nasal Decongestants; D010080:Oxazoles; D011955:Receptors, Drug; D015016:Yohimbine; D000077769:Rilmenidine; C010242:metizoline